...CVR) payable upon receipt of an FDA notice by Dec. 31, 2021, recognizing that Bonsity teriparatide...

...Laboratories. His drug development successes include diabetes drug Humalog insulin lispro and osteoporosis drug Forteo teriparatide...

...siponimod Treat secondary progressive multiple sclerosis (SPMS) MAA action YE19 Pfenex Inc . (NYSE-M:PFNX) biosimilar teriparatide...

...a 12-month treatment course based on the supporting clinical trials on its U.S. label. Forteo teriparatide...

...Pfenex Inc. (NYSE-A:PFNX) announced an Oct. 7 PDUFA date for PF708, its biosimilar of Forteo teriparatide...

...Pfenex Inc. (NYSE-A:PFNX) announced an Oct. 7 PDUFA date for PF708, its biosimilar of Forteo teriparatide...

...NDA to FDA for lead candidate PF708, which is a biosimilar of osteoporosis drug Forteo teriparatide...

...in sales. The price cut did allow Tymlos to replace Eli Lilly and Co.’s Forteo teriparatide...

...BioCentury, Oct. 24, 2016) . Lilly reported that first quarter sales of osteoporosis drug Forteo teriparatide...

...or no competition.” The new guidance is aimed specifically at ANDAs for glucagon, liraglutide, nesiritide, teriparatide...